Aperio Group’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $52.6M | Buy |
260,346
+18,108
| +7% | +$3.75M | 0.16% | 125 |
|
|
2020
Q3 | $50.9M | Buy |
242,238
+9,873
| +4% | +$2.2M | 0.17% | 107 |
|
|
2020
Q2 | $51M | Buy |
232,365
+47,409
| +26% | +$9.47M | 0.19% | 102 |
|
|
2020
Q1 | $32M | Buy |
184,956
+49,196
| +36% | +$8.13M | 0.14% | 154 |
|
|
2019
Q4 | $20.8M | Sell |
135,760
-798
| -0.6% | -$119K | 0.07% | 281 |
|
|
2019
Q3 | $20.7M | Sell |
136,558
-1,825
| -1% | -$289K | 0.08% | 284 |
|
|
2019
Q2 | $21.2M | Sell |
138,383
-7,490
| -5% | -$1.14M | 0.09% | 271 |
|
|
2019
Q1 | $23.4M | Buy |
145,873
+5,441
| +4% | +$844K | 0.1% | 222 |
|
|
2018
Q4 | $21.6M | Buy |
140,432
+4,100
| +3% | +$639K | 0.11% | 214 |
|
|
2018
Q3 | $20.5M | Buy |
136,332
+3,933
| +3% | +$559K | 0.09% | 250 |
|
|
2018
Q2 | $17.9M | Sell |
132,399
-15,671
| -11% | -$1.93M | 0.09% | 268 |
|
|
2018
Q1 | $19.7M | Buy |
148,070
+5,516
| +4% | +$741K | 0.1% | 242 |
|
|
2017
Q4 | $21.2M | Buy |
142,554
+4,522
| +3% | +$615K | 0.11% | 219 |
|
|
2017
Q3 | $18.2M | Buy |
138,032
+12,330
| +10% | +$1.66M | 0.1% | 234 |
|
|
2017
Q2 | $16.7M | Buy |
125,702
+7,995
| +7% | +$1.08M | 0.1% | 230 |
|
|
2017
Q1 | $15.9M | Buy |
117,707
+8,860
| +8% | +$1.15M | 0.11% | 218 |
|
|
2016
Q4 | $13.1M | Buy |
108,847
+8,427
| +8% | +$994K | 0.1% | 233 |
|
|
2016
Q3 | $12.6M | Buy |
100,420
+10,362
| +12% | +$1.36M | 0.09% | 261 |
|
|
2016
Q2 | $12.5M | Buy |
90,058
+51
| +0.1% | +$6.61K | 0.1% | 242 |
|
|
2016
Q1 | $11.3M | Buy |
90,007
+10,528
| +13% | +$1.34M | 0.1% | 246 |
|
|
2015
Q4 | $10.1M | Buy |
79,479
+9,356
| +13% | +$1.16M | 0.09% | 255 |
|
|
2015
Q3 | $8.1M | Buy |
70,123
+10,982
| +19% | +$1.23M | 0.08% | 293 |
|
|
2015
Q2 | $6.15M | Buy |
59,141
+7,929
| +15% | +$856K | 0.06% | 352 |
|
|
2015
Q1 | $5.65M | Buy |
51,212
+3,511
| +7% | +$381K | 0.06% | 374 |
|
|
2014
Q4 | $4.97M | Buy |
47,701
+4,288
| +10% | +$429K | 0.06% | 380 |
|
|
2014
Q3 | $4.17M | Buy |
43,413
+4,163
| +11% | +$376K | 0.06% | 399 |
|
|
2014
Q2 | $3.59M | Sell |
39,250
-859
| -2% | -$76.9K | 0.05% | 426 |
|
|
2014
Q1 | $3.53M | Buy |
+40,109
| New | +$3.52M | 0.05% | 491 |
|
|
2013
Q4 | – | Sell |
-27,679
| Closed | -$2.49M | – | 442 |
|
|
2013
Q3 | $2.26M | Buy |
27,679
+6,594
| +31% | +$557K | 0.04% | 538 |
|
|
2013
Q2 | $1.75M | Buy |
+21,085
| New | +$1.81M | 0.04% | 550 |
|
Other funds holding CLX
CRC
Aperio Group's CLX Position: Q4 2020 in Review
Aperio Group increased its Clorox (CLX) stake by 7.5% in Q4 2020, buying an estimated $3.75M and bringing the position to 260,346 shares worth $52.6M. The position accounts for 0.16% of the portfolio, ranked #125.
Aperio Group first reported a position in CLX in Q2 2013 and has held it in 30 quarters since. 1,263 funds tracked by Wall St. Rank hold CLX as of Q4 2020.
- Aperio Group held 260,346 shares of Clorox worth $52.6M as of Q4 2020.
- Aperio Group bought 18,108 Clorox shares in Q4 2020, an estimated $3.75M.
- Clorox made up 0.16% of Aperio Group's portfolio in Q4 2020, its #125 holding.
- Aperio Group first reported a position in Clorox in Q2 2013 and has held it in 30 quarters since.
- 1,263 funds tracked by Wall St. Rank held Clorox as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.